Educational Meetings

Cardinal Clinic is committed to providing Continual Professional Development. As part of this commitment, we provide a monthly tutorial for GPs and healthcare professionals.

The meeting starts at 7.30pm and finishes at 9.30pm. A buffet supper is provided and CPD certificate awarded.

Please note: the content of the meeting is targeted to GPs and healthcare professionals and therefore we cannot extend the invitation to patients, their families or carers.

Booking your attendance

If you would like to attend, please call Louise De Haan on 01753 848503 or email [email protected]

< 2018 >
August
«
»
Mon
Tue
Wed
Thu
Fri
Sat
Sun
July
July
1
2
3
4
5
6
7
8
9
10
11
12
13
  • Using Biomarkers in the Diagnosis of Cognitive Disorders & Dementia
    19:30 -21:30
    13-08-2018

    Cardinal Clinic, Oakley Green Road, Windsor, United Kingdom

    Cardinal Clinic, Oakley Green Road, Windsor, United Kingdom

    Dr Paul Loughlin, Consultant Psychiatrist

    Despite 20 years without a serious breakthrough in the treatment of dementia  we still need to focus on improving the early identification of individuals in the pre-symptomatic stages of Alzheimer’s disease and other dementias to enable potential new disease modifying treatments to have more impact.  Biomarker combinations may be more useful than single diagnostic tests to assist physicians in assessing the risk of future cognitive decline. Examples of biomarkers include Amyloid protein detected on a brain PET scan, Amyloid and Tau protein in the CSF and hippocampal volume.

    Combining neurodegeneration biomarkers with cognitive severity may help refine earlier diagnosis. New biomarker criteria for preclinical Alzheimer’s disease will be discussed including A-T-N (Amyloid-Tau-Neurodegeneration). The biomarker-based concept of Suspected non-Alzheimer’s pathophysiology (SNAP) will also be explored.  I will discuss newer biomarkers including serum neurofilament light, which has been tested as a marker of early familial Alzheimer disease (FAD). Direct and indirect biomarkers in non-AD dementias will be covered. I will take us through modifiable risk factors for dementia and how a personalised approach to prevention of dementia might be achieved.

14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
September
September